학술논문

Phase II open-label, single-arm trial to investigate the efficacy and safety of topical remetinostat gel in patients with basal cell carcinoma
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 September 2021, 27(17):4717-4725)
Subject
Language
English
ISSN
15573265
10780432